SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma

SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma

Bibliographic Details
Main Authors:	Zihang Zeng, Yanping Gao, Jiali Li, Jianguo Zhang, Yangyi Li, Fajian He, Zhengrong Huang, Linzhi Han, Yan Gong, Conghua Xie
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2023-03-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304222000721

Similar Items

SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma
by: Zihang Zeng, et al.
Published: (2022-08-01)

GPR87 promotes tumor cell invasion and mediates the immunogenomic landscape of lung adenocarcinoma
by: Rui Bai, et al.
Published: (2022-07-01)

An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis
by: Liexi Xu, et al.
Published: (2022-08-01)

SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma
by: Yangyi Li, et al.
Published: (2022-12-01)

LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
by: Yanping Gao, et al.
Published: (2022-04-01)

RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
by: Xueping Jiang, et al.
Published: (2021-04-01)

Correction: RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
by: Xueping Jiang, et al.
Published: (2022-09-01)

Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis
by: Zihang Zeng, et al.
Published: (2021-08-01)

Integrated analysis reveals common DNA methylation patterns of alcohol-associated cancers: A pan-cancer analysis
by: Xingyu Liu, et al.
Published: (2023-02-01)

Investigating the functional role of SETD6 in lung adenocarcinoma
by: Jing Xu, et al.
Published: (2023-01-01)

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy
by: Weijing Dai, et al.
Published: (2022-04-01)

Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
by: Xingyu Liu, et al.
Published: (2020-10-01)

Prediction of radiosensitivity and radiocurability using a novel supervised artificial neural network
by: Zihang Zeng, et al.
Published: (2022-12-01)

Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer
by: Chen Jie, et al.
Published: (2023-02-01)

Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy
by: Mingdong Lu, et al.
Published: (2021-06-01)

Inhibition of histone methyltransferase SETD8 represses DNA virus replication
by: Lin Chen, et al.
Published: (2022-06-01)

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
by: Xiaobin Zheng, et al.
Published: (2023-07-01)

Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts
by: Zihang Zeng, et al.
Published: (2022-01-01)

Pan-cell death-related signature reveals tumor immune microenvironment and optimizes personalized therapy alternations in lung adenocarcinoma
by: Linzhi Han, et al.
Published: (2024-07-01)

Biomineralized Manganese Oxide Nanoparticles Synergistically Relieve Tumor Hypoxia and Activate Immune Response with Radiotherapy in Non-Small Cell Lung Cancer
by: Xinyu Liu, et al.
Published: (2022-09-01)

A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation
by: Hira Javaid, et al.
Published: (2023-08-01)

Setd2 inactivation sensitizes lung adenocarcinoma to inhibitors of oxidative respiration and mTORC1 signaling
by: David M. Walter, et al.
Published: (2023-03-01)

The role of SETD3 in the immune system
by: Bunjamin, Maegan
Published: (2020)

Agrin Promotes Non-Small Cell Lung Cancer Progression and Stimulates Regulatory T Cells via Increasing IL-6 Secretion Through PI3K/AKT Pathway
by: Linzhi Han, et al.
Published: (2022-01-01)

The DNA damage response in immunotherapy and radiation
by: Robert M. Samstein, MD, PhD, et al.
Published: (2018-10-01)

The EV71 2A protease occupies the central cleft of SETD3 and disrupts SETD3-actin interaction
by: Xiaopan Gao, et al.
Published: (2024-05-01)

SETD8, a frequently mutated gene in cervical cancer, enhances cisplatin sensitivity by impairing DNA repair
by: Xin Wang, et al.
Published: (2023-06-01)

Histone acetylation-related IncRNA: Potential biomarkers for predicting prognosis and immune response in lung adenocarcinoma, and distinguishing hot and cold tumours
by: Rumeng Li, et al.
Published: (2023-03-01)

Structure, activity and function of the lysine methyltransferase SETD5
by: Mingyang Li, et al.
Published: (2023-02-01)

Radiotherapy for Melanoma: More than DNA Damage
by: Susanne J. Rogers, et al.
Published: (2019-01-01)

USP29 Deubiquitinates SETD8 and Regulates DNA Damage-Induced H4K20 Monomethylation and 53BP1 Focus Formation
by: Yeray Hernández-Reyes, et al.
Published: (2022-08-01)

Functional characterization and physiological significance of SETD3
by: Chia, Shyh Jenn
Published: (2017)

Phenotypic characterization of SETD3 knockout Drosophila.
by: Marcel Tiebe, et al.
Published: (2018-01-01)

Proteomic analysis of SETD6 interacting proteins
by: Ofir Cohn, et al.
Published: (2016-03-01)

Successful treatment of induced oligometastasis and repeated oligoprogression of advanced lung adenocarcinoma with immunotherapy and radiotherapy
by: Ho Young Lee, et al.
Published: (2022-07-01)

DNA Damage Repair in Brain Tumor Immunotherapy
by: Shihong Zhao, et al.
Published: (2022-01-01)

Histone methyltransferase SETD1A participates in lung cancer progression
by: Mei Du, et al.
Published: (2021-08-01)

Coexistence of a novel SETD2-ALK, EML4-ALK double-fusion in an advanced lung adenocarcinoma patient after alectinib resistant and response to immunotherapy combined with chemotherapy: a case report
by: Lin Zhu, et al.
Published: (2023-04-01)

SETD2 mutations in primary central nervous system tumors
by: Angela N. Viaene, et al.
Published: (2018-11-01)

SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint
by: Sílvia Carvalho, et al.
Published: (2014-05-01)